Sequans Communications S.A. uses Form 6-K reports to document its foreign-private-issuer disclosures for a France-based issuer whose American depositary shares represent ordinary shares. The filings include unaudited financial results, press-release exhibits, incorporation by reference into Form S-8 and Form F-3 registration statements, and disclosures tied to its 4G/5G cellular IoT semiconductor business.
Recent filings also cover shareholder meeting materials under French corporate law, ADS voting and ordinary-share capital actions, board and management changes, NYSE continued-listing compliance, secured convertible debenture arrangements, and Bitcoin digital-asset treasury matters. These records frame Sequans’ governance, capital structure, registration capacity, and public-company reporting obligations.
Sequans Communications S.A. (NYSE: SQNS) has received a NYSE notice of non-compliance with Section 802.01B covering minimum global market capitalization and shareholders’ equity. Over the past 30 consecutive trading days the company’s average market cap fell below US$50 million and its stockholders’ equity is also under US$50 million, triggering the deficiency.
The notification does not cause immediate delisting. Sequans must, within 90 days (by 7 September 2025), submit a detailed business plan demonstrating how it will regain compliance within a 9-month cure period. The NYSE will respond to the plan within 45 days of receipt. During this period, the American Depositary Shares will continue to trade under ticker “SQNS” but will carry the suffix “.BC” to indicate “below compliance”.
Failure to meet the plan milestones or restore market capitalization/equity levels within the specified timeframe could result in suspension and delisting. Management states that it is “evaluating available options” and intends to cure the deficiency; no specific actions or financial measures were disclosed in the filing.
Sequans Communications S.A. (NYSE: SQNS) has received a NYSE notice of non-compliance with Section 802.01B covering minimum global market capitalization and shareholders’ equity. Over the past 30 consecutive trading days the company’s average market cap fell below US$50 million and its stockholders’ equity is also under US$50 million, triggering the deficiency.
The notification does not cause immediate delisting. Sequans must, within 90 days (by 7 September 2025), submit a detailed business plan demonstrating how it will regain compliance within a 9-month cure period. The NYSE will respond to the plan within 45 days of receipt. During this period, the American Depositary Shares will continue to trade under ticker “SQNS” but will carry the suffix “.BC” to indicate “below compliance”.
Failure to meet the plan milestones or restore market capitalization/equity levels within the specified timeframe could result in suspension and delisting. Management states that it is “evaluating available options” and intends to cure the deficiency; no specific actions or financial measures were disclosed in the filing.
Sequans Communications S.A. (SQNS) has furnished a Form 6-K to the U.S. SEC. The filing, dated 20 June 2025, states that on 23 June 2025 the company issued a press release announcing it had signed definitive agreements to issue equity and convertible debt in concurrent private placements. The press release is provided as Exhibit 99.1 and is incorporated by reference into numerous effective registration statements, including multiple Form S-8 and two Form F-3 shelves. The document contains no financial statements, proceeds amounts or pricing terms. The submission was signed by Chief Financial Officer Deborah Choate.
The filing therefore serves solely to place the related financing announcement into the company’s U.S. disclosure record and to make it automatically available for prospectus incorporation.
Sequans Communications S.A. (SQNS) has furnished a Form 6-K to the U.S. SEC. The filing, dated 20 June 2025, states that on 23 June 2025 the company issued a press release announcing it had signed definitive agreements to issue equity and convertible debt in concurrent private placements. The press release is provided as Exhibit 99.1 and is incorporated by reference into numerous effective registration statements, including multiple Form S-8 and two Form F-3 shelves. The document contains no financial statements, proceeds amounts or pricing terms. The submission was signed by Chief Financial Officer Deborah Choate.
The filing therefore serves solely to place the related financing announcement into the company’s U.S. disclosure record and to make it automatically available for prospectus incorporation.